FOLFOX-Encorafenib/Panitumumab Regimen

Preferred Label : FOLFOX-Encorafenib/Panitumumab Regimen;

NCIt synonyms : Folinic Acid/Fluorouracil/Oxaliplatin/Encorafenib/Panitumumab Regimen; FOLFOX-Panitumumab/Encorafenib; FOLFOX-Encorafenib-Panitumumab; Leucovorin/Fluorouracil/Oxaliplatin/Encorafenib/Panitumumab; Leucovorin-Fluorouracil-Oxaliplatin-Encorafenib-Panitumumab; FOLFOX Plus Panitumumab/Encorafenib; FOLFOX Plus Encorafenib/Panitumumab; Encorafenib/Fluorouracil/Leucovorin/Oxaliplatin/Panitumumab; FOLFOX Plus Braftovi-Vectibix; Encorafenib/Panitumumab Plus FOLFOX; Panitumumab/Encorafenib Plus FOLFOX; Encorafenib-Panitumumab-FOLFOX; Panitumumab/Encorafenib-FOLFOX; FOLFOX- Vectibix/Braftovi; FOLFOX/Panitumumab/Encorafenib; FOLFOX/Encorafenib/Panitumumab;

NCIt definition : A regimen consisting of leucovorin, fluorouracil and oxaliplatin (FOLFOX) plus encorafenib and panitumumab that is used for the treatment of colorectal cancer.;

Détails

Origin ID

C215162;

chemotherapy_regimen_has_component
- Encorafenib [NCIt concept]
- Fluorouracil [NCIt concept]
- Leucovorin Calcium [NCIt concept]
- Oxaliplatin [NCIt concept]
- Panitumumab [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
regimen_has_accepted_use_for_disease
- Colorectal Carcinoma [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients